Bristol-Myers' Smart Moves
634762
Although problems still hang over the company, Bristol-Myers is paving the way for recovery.
524145
The drugstore company's clinic acquisition shows it's aggressively chasing current trends.
125318
The decision removes a weighty uncertainty for Bristol-Myers Squibb and Sanofi-Aventis, the companies that market the product.
710690
Is the company's push into nutritional supplements a wise move?
640990
Now might be a great time to load up on cutting-edge drug makers.
610018
New technology could lead to safer, more effective drugs.
675913
Eli Lilly and Co. said its strategy of staying independent and plowing money into research should pay off in 2005, with profits expected to jump 8 percent to 12 percent over 2004 and nine new drugs in advanced human testing.
174409
The company's lead drug will enter phase 1 trials, bringing potential good fortune to investors.
753455
Pfizer to investors: Don't stop believing.
574845
A six-step plan to identifying great growth stocks -- and riding their success.
687321
A few smart moves can fast-track your retirement.
234877
Through its acquisition of Healthology, the company's bottom line should gain strength.
131142
NEW YORK/LONDON  - Several of the world's top   drugmakers may weigh acquiring Bristol-Myers Squibb Co. BMY.N   after it fired its chief executive, although suitors seem   unlikely to bid before next summer, analysts said.
573459
A key study of its lead drug proceeds faster than expected.
492501
The biopharmaceutical company removes some uncertainty by teaming up with Novartis.
751523
A new addition to an already successful drug promises good results for investors.
494020
Big opportunities await patient investors in nanotech, cleantech, and robotics.